Advances in genome sequencing have progressed at a rapid pace, with increased
throughput accompanied by plunging costs. But these advances go far beyond faster and …

Increasing evidence suggests that circulating tumour cells (CTCs) are responsible for
metastatic relapse and this has fuelled interest in their detection and quantification. Although …

Lung cancer has a high mortality rate, but an early diagnosis can contribute to a favorable
prognosis. A liquid biopsy that captures and detects tumor-related biomarkers in body fluids …

The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid
malignant tumors becomes increasingly important as it may serve as a 'liquid biopsy'with the …

Background The assessment of cell-free circulating DNA fragments, also known as a" liquid
biopsy" of the patient's plasma, is an important source for the discovery and subsequent non …

Lung cancer remains one of the most common and malignant cancers worldwide. It is most
often diagnosed at late stages, when it has already presented local invasion and distal …

Background This systematic review aimed to gather evidence from research on the current
state of liquid biopsy in medical practice, specifically focusing on mutation detection and …

Epithelial-mesenchymal transition (EMT) is a key process in embryonic development and
metastases formation during malignant progression. This review focuses on transcriptional …

Circulating tumor cells (CTCs) escape from primary or metastatic lesions and enter into
circulation, carrying significant information of cancer progression and metastasis. Capture of …

Lung cancer is a kind of malignant tumor with rapid progression and poor prognosis. Distant
metastasis has been the main cause of mortality among lung cancer patients. Bone is one of …